AMICUS THERAPEUTICS, INC. — Director's Dealing 2015

Jul 15, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2015-07-13

Reporting Person: SBLENDORIO GLENN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-07-13	Common stock	M	10000	$15.00	Acquired	21933	Direct
2015-07-13	Common stock	S	10000	$15.00	Disposed	11933	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-07-13	Stock Options (right to buy)	$10.53	M	10000	Disposed	2018-06-10	Common Stock (10000)	Direct

Footnotes

F1: The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2014.